Semigran Marc has filed 6 insider transactions across 1 company since August 2024.
Most recent transaction: a option exercise of 29709 shares of Edgewise Therapeutics, Inc. ($EWTX) on December 24, 2024.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 24, 2024 | Edgewise Therapeutics, Inc. | $EWTX | Semigran Marc | Chief Development Officer | M | Common Stock | 29709 | $8.94 | 36,425.0000 | 93,813,346 | 442.36% | 0.03% |
| Dec. 24, 2024 | Edgewise Therapeutics, Inc. | $EWTX | Semigran Marc | Chief Development Officer | S | Common Stock | 27980 | $29.66 | 8,445.0000 | 93,813,346 | 76.82% | 0.03% |
| Dec. 24, 2024 | Edgewise Therapeutics, Inc. | $EWTX | Semigran Marc | Chief Development Officer | S | Common Stock | 1729 | $30.08 | 6,716.0000 | 93,813,346 | 20.47% | 0.00% |
| Dec. 24, 2024 | Edgewise Therapeutics, Inc. | $EWTX | Semigran Marc | Chief Development Officer | M | Stock Option (Right to Buy) | 29709 | $0.00 | 270,291.0000 | 93,813,346 | 9.90% | 0.03% |
| Aug. 12, 2024 | Edgewise Therapeutics, Inc. | $EWTX | Semigran Marc | Chief Development Officer | A | Stock Option (Right to Buy) | 138750 | $0.00 | 138,750.0000 | 93,515,356 | 9999.99% | 0.15% |
| Aug. 12, 2024 | Edgewise Therapeutics, Inc. | $EWTX | Semigran Marc | Chief Development Officer | A | Restricted Stock Units | 23125 | $0.00 | 23,125.0000 | 93,515,356 | 9999.99% | 0.02% |